Aptevo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$17,411,000 over the previous period. Total operating expenses were $28,878,000.
Profit Margin
| 2014 | 45.63M | -51.11M | -112.02% |
|---|---|---|---|
| 2015 | 33.60M | -59.31M | -176.53% |
| 2016 | 36.43M | -112.41M | -308.54% |
| 2017 | 14.65M | 6.97M | 47.57% |
| 2018 | 23.06M | -53.68M | -232.75% |
| 2019 | 32.42M | -40.44M | -124.75% |
| 2020 | 4.30M | -18.44M | -428.13% |
| 2021 | 12.29M | -27.31M | -222.2% |
| 2022 | 3.11M | 42.66M | 1370.23% |
| 2023 | 0 | -17.41M |
APVO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 3.11M | 12.29M | 4.30M | 32.42M | 23.06M | 14.65M | 36.43M | 33.60M | 45.63M |
Cost of revenue | 567K | 901K | 18.99M | 17.85M | 19.92M | 11.21M | 5.01M | 24.18M | 16.93M | 16.25M |
Gross profit | -567K | 2.21M | -6.70M | -13.54M | 12.49M | 11.85M | 9.64M | 12.25M | 16.66M | 29.37M |
Operating exp. | ||||||||||
Research and development | 17.10M | 17.88M | 18.99M | 17.85M | 24.76M | 35.38M | 29.02M | 29.51M | 34.72M | 46.58M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 28.87M | 31.75M | 33.69M | 31.80M | 40.96M | 63.51M | 63.59M | 68.18M | 77.76M | 80.86M |
Operating income | -28.87M | -28.64M | -21.4M | -27.49M | -40.96M | -51.66M | -53.94M | -126.94M | -61.1M | -51.49M |
Other income (expenses), net | 10.22M | 35.65M | -8.00M | -3.42M | -2.10M | -2.02M | -1.94M | -71.82M | -237K | -222K |
Income before tax | -18.65M | 7.01M | -29.40M | -30.92M | -43.06M | -53.68M | -55.89M | -127.75M | -61.33M | -51.71M |
Income tax expense | 0 | -35.65M | -2.09M | -12.47M | -2.61M | -2.02M | -23.30M | -15.34M | -2.02M | -599K |
Net income | -17.41M | 42.66M | -27.31M | -18.44M | -40.44M | -53.68M | 6.97M | -112.41M | -59.31M | -51.11M |
Earnings per share | ||||||||||
Basic EPS | -62.62 | 366.71 | -256.35 | -239.38 | -610.11 | -1.46K | -941.01 | -3.64K | -1.80K | -1.55K |
Diluted EPS | -62.62 | 367.92 | -256.35 | -239.38 | -610.11 | -1.46K | -941.01 | -3.64K | -1.80K | -1.55K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |